Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.10−0.51 (-7.72%)
Close on Nov 18, 2026Market cap $24.59MP/E –Yield –
Rockwell Medical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Rockwell Medical
Rockwell Medical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?